Betasciencepress.com | STM Publishing Corporation                                                                                                                                             

Editorial Board

 

Roland J.W. Meesters, BSc BSc MSc PhD, (InHolland University of Applied Sciences, Amsterdam, the Netherlands & Universidad de los Andes, Bogotá D.C., Colombia). 
earned his Ph.D in Bioanalytical Chemistry at Erasmus University Rotterdam in the Netherlands. He is Adjunct Professor of Analytical Chemistry at the los Andes University in Bogota D.C., Colombia and Senior Lecturer at Inholland University of Apllied Sciences in Amsterdam, the Netherlands. In his current positions he is responsible for teaching (bio)analytical chemistry and other chemistry courses; he is head of the GABIO research group. Dr. Meesters research focuses on bioanalytical sciences and he has a specific interest in metabolomics, therapeutic drug monitoring and PK modeling and in the role of metabolites in biological processes and in diseases. He is a specialist in the development and application of quantitative bioanalytical techniques particularly involving LC in combination with mass spectrometry. 
This email address is being protected from spambots. You need JavaScript enabled to view it.
 
 Jeffery Hackett, MSc PhD D-ABFT CSci CChem FRSC (Forensic Laboratory Division, Office of Chief Medical Examiner, San Francisco, USA).
received from the Royal Society of Chemistry (Grad.RSC), Chartered Chemist (CChem) and Chartered Scientist (CSci) status. He holds a MSc degree in Instrumental Chemical Analysis, and a PhD in Forensic Analytical Toxicology from Liverpool John Moores University. Dr. Hackett is a member of SOFT, TIAFT, and a Fellow of AAFS and as well as a Fellow of the Royal Society of Chemistry. Dr. Hackett's research interests lie in the area of Solid Phase Extraction (SPE) of drugs/poisons from difficult matrices such as post mortem fluids/tissues and analysis by chromatographic systems coupled to mass spectrometers. In 2014, Dr. Hackett was awarded Diplomate status of the American Board of Forensic Toxicology (D-ABFT).
This email address is being protected from spambots. You need JavaScript enabled to view it.
 
Irene Panderi BSc PhD, (University of Athens, Athens, Greece).
Associate Professor in Pharmaceutical Analysis in the School of Pharmacy, Division of Pharmaceutical Chemistry at the University of Athens, Greece. She graduated from the University of Athens with a degree in pharmacy and received a PhD in pharmaceutical analysis. Her postdoctoral research involved QSAR studies as well as pharmaceutical analysis and stability studies. In 2013 she performed a 1-year sabbatical training in MALDI-TOF mass spectrometry imaging at the Warren Alpert Medical School, Brown University, RI, USA. Dr. Panderi's research focuses on pharmaceutical analysis by HPLC, fluorescence derivatization, LC-ESI/MS, LC-iontrap MS, LC-οαTOF-MS, UPLC-ESI tandem MS and LC-qTOF-MS methods; Imaging Mass Spectrometry for cancer research; Bioequivalence studies; Stability studies and Quality control of pharmaceuticals and cosmetics; Doping control.
This email address is being protected from spambots. You need JavaScript enabled to view it.
 
Leimin Fan BSc PhD, (RockTown Technology and Service, Libertyville, IL, USA).
obtained his Ph.D. degree of Physical Organic Chemistry from University of Memphis. He has been working in the pharmaceutical industry as an analytical chemist for more than 15 years. His expertise includes peptide purification and analysis, API analysis, stability evaluation, HPLC and LC/MS/MS method development and validation, GLP regulated bioanalysis for non-clinical and clinical studies. In recent years, Dr. Fan has emphasized his research on new technologies and automated processes to improve bioanalysis efficiency. He invented the DMPD (dried matrix on paper disc) technology to improve DBS performance by reduce and eliminate its hematocrit effect.
This email address is being protected from spambots. You need JavaScript enabled to view it.
 
Lùcia Carrano PhD, (Fondazione Instituto Insubrico Ricerca per La Vita, Gerenzano, Italy).
recieved her PhD in Chemical Sciences at the University of Napoli. Dr Carrano is Principal Scientist at FIIRV, a private research foundation, her research projects concern purification, characterization, novelty evaluation of protein and organic molecules from fermentations broths; evaluation of their potential in programs concerning different therapeutic area; methods development and pharmacokinetic analysis; studies on mechanisms of resistance in antibiotic producers. Dr Carrano tutored on natural products, HTS, data handling, assay development, early phase of drug discovery. She was Contract Professor at the Faculty of Science at the University of Napoli and Viterbo and is recognized as Qualified Person by AIFa and appointed as member of the Chemists Order Disciplinary Council (Lombardia).
lThis email address is being protected from spambots. You need JavaScript enabled to view it.
 
Alexander Buko PhD,(Human Metabolome Technologies, Boston, MA, USA).
received his Ph.D. in 1980 from the University of Virginia in protein bioanalytical chemistry using paper electrophoresis and HPLC. He went onto the Bureau of Biologics and Biophysics for four years then moved to Abbott Labs for 18 years leading analytics in metabolomics, proteomics, quantitation and structural characterization of small molecules and proteins using LCMS, NMR, surface microscopy and biophysical technologies. From 2002 to 2012 Alex was Sr. Director Translational Medicine at BiogenIdec responsible for protein analytics, proteomics, metabolomics and quantitative bioanalysis using FTMS, Imaging MS, UV and MS/MS. Currently he is Vice President of Business and Product Development for Human Metabolome Technologies (HMT). Since 2002, HMT has focused on delivering comparative and quantitative metabolic profiling to research communities using CEMS and LCMS.
This email address is being protected from spambots. You need JavaScript enabled to view it.
 
Sophie Ayciriex MSc PhD, (ANABIO-MS Laboratory, Institute of Analytical Sciences, Villeurbanne, France).
earned her M.Sc. degree in Biochemistry and Structural Biology at the University Paul Sabatier (Toulouse, France). She obtained her european Ph.D. degree in Biochemistry in 2010 at the University Bordeaux Segalen, France. During her PhD fellowship, she investigated the characterization of a novel lysolipid acyltransferase in S. cerevisiae by combining several biochemistry tools and lipidomics. For her first post-doctoral fellowship, she joined the University Paris Descartes – Faculty of Pharmacy (CNRS UMR 8638) in Paris, France. She developed analytic methods for the analysis of sterols and oxysterols by UPLC-ESI-HRMS and conducted lipidomics research in relation with neurodegeneration. She is currently pursuing her postdoc in analytical chemistry, performing shotgun Lipidomics on high-resolution mass spectrometry at Max Planck Institute of Molecular Cell Biology and Genetics in Dresden, Germany. System biology of lipid metabolism is one of her main research.
aThis email address is being protected from spambots. You need JavaScript enabled to view it.
 
William van Dongen PhD, (ProQR Therapeutics NV, Utrecht, the Netherlands).
holds a PhD in peptide and protein mass spectrometry (MS).He worked as industrial researcher, project manager and laboratory manager in the field of bioanalytical MS and liquid chromatography (LC)-MS and was responsible for setting up the bioanalytical LC-MS facility of Pharma Bio-Research (currently PRA International). He has almost ten years experience as study director of bioanalytical LC-MS studies. He also set-up MS facilities for the generic pharmaceutical companies Synthon, Prosensa and for PROXY, a pharma contract laboratory. William's main scientific expertise is in the development and validation of quantitative bioanalytical methods for small molecule, peptide and biopharmaceutical drugs and their metabolites in biological fluids (plasma, urine, tissue, etc.). These methods are essential for the pharma industry to generate the necessary (pre)clinical toxicokinetic (TK), pharmacokinetic (PK), bioavailability, and metabolic stability data and development of analytical (metabolomics) tools for the discovery of biomarkers and bioactive compounds.
This email address is being protected from spambots. You need JavaScript enabled to view it.
 
Sakda Khoomrung MSc PhD, (Chalmers University, Göteborg, Sweden).
obtained a master degree in analytical chemistry from Prince of Songkhla University, Thailand and PhD in analytical chemistry from Karl-Franzens University, Austria in 2011. His current research is focused on the development of analytical methods to support metabolomics/lipidomics research. The methods are based on HPLC and GC coupled with different detectors to provide both quantitative and qualitative analysis. The applications of the developed method are mostly applied to medical, food and yeast research. He also has work intensively with novel sample preparation technique (e.g., microwave technology) in order to provide an opportunity for high though-put analysis.
This email address is being protected from spambots. You need JavaScript enabled to view it.
 
Jennifer Knaack PhD, (Mercer University, Atlanta, GA, USA).
Assistant Professor in the Department of Pharmaceutical Sciences in the College of Pharmacy. She received her Ph.D. in Pharmaceutical Sciences from the University of Southern California where she studied the structure of an intestinal drug transporter. Following her graduate studies, Dr. Knaack was a postdoctoral fellow at Lawrence Livermore National Laboratory where she studied yeast metabolism using accelerator mass spectrometry. Dr. Knaack then spent four years at the Centers for Disease Control and Prevention in Atlanta, GA where she developed novel diagnostic methods for measuring human exposure to organophosphorus nerve agents and paralytic shellfish toxins. Now at Mercer University, Dr. Knaack develops innovative diagnostic methods for measuring exposure to environmental and synthetic toxins. She teaches in several courses including gastrointestinal and renal anatomy, physiology and pharmacology as well as analytical methods and instrumentation.
This email address is being protected from spambots. You need JavaScript enabled to view it.
 
Rob J. Vreeken PhD, (Discovery Sciences, Janssen Pharmaceutica, Beerse, Belgium).
received his Ph.D. from the Free University of Amsterdam (NL). Hereafter, he developed and applied a variety of MS-based techniques for quantitative and qualitative analysis in academic and commercial settings (PD at EPFL (Lausanne, CH) and group leader at KWR (Netherlands Drinking Water Research facility) and TNO (CRO and research institute)). Subsequently, he headed the Waters EU applications, training, demonstration and support organisations. After leading the pharma-unit at Avantium (CRO, Amsterdam, NL) he joined the Netherlands Metabolomics Centre (Leiden Academic Centre for Drug Research, Leiden University, NL) as Assistant Professor to create and direct the Central Lab facility. Next to teaching, he developed novel strategies for e.g. (endogenous) metabolite identification and advanced lipidomics, which were used for biomarker discovery in inflammatory processes. From July 2014 he directs a team at Janssen Pharmaceutica (Johnson & Johnson, Beerse, Belgium) focusing on early stage pathway engagement studies, bio-analysis and biomarker validation.
This email address is being protected from spambots. You need JavaScript enabled to view it.
 
Ganesh Moorthy Bsc MSc PhD, (The Children´s Hospital of Philadelphia, Philadelphia, PA, USA).
completed B.Sc. from Bharathiyar University, M.Sc. from Indian Institute of Technology, Chennai, India and Ph.D. from Case Western Reserve University Cleveland, Ohio. Dr. Moorthy graduate research was on the development of immunoassays for levuglandin-protein conjugates and total synthesis of levuglandins. In his post-graduate studies at UCLA School of Medicine, Dr. Moorthy discovered a novel pathway of biologically active phospholipids. In 2002, Dr. Moorthy joined Drug Metabolism and Pharmacokinetics department of GlaxoSmithKline and contributed to quantitative and qualitative bioanalysis. Dr. Moorthy was a part of the team that discovered Tafinlar (FDA approval in 2013). In 2009 Dr. Moorthy joined Center for Clinical Pharmacology at The Children's Hospital of Philadelphia and working on several pediatric drug development projects. Dr. Moorthy's research focus is development, validation and utilization of liquid chromatography-tandem mass spectrometry (LC-MS/MS) based assays for pediatric pharmacokinetic and pharmacodynamics (PK/PD) analysis of drugs and metabolites.
This email address is being protected from spambots. You need JavaScript enabled to view it.
 
GC96x96Graeme T Clark PhD FRSC, (Cyprotex, Macclesfield, UK).
Graeme has been working in the field of Pharmaceutical and Analytical sciences since obtaining his PhD in Bio-organic Chemistry from the University of Southampton in 1999. He is presently the Head of Bioanalytical Sciences at Cyprotex. His interests in the application of separation sciences and mass spectrometry in the life sciences has provided him with a diverse background having been operationally and technically responsible for functions that include LC-MS based lipidomics, Discovery DMPK support and Regulatory Bioanalysis (Pre-clinical TK support through to Multi-Site Phase IIb clinical Studies). His current interests include application of LC-MS in support of biopharmaceutical analysis, microsampling techniques and unlabelled, trace analysis of microdosing samples. He is also heavily involved with the Drug Metabolism Discussion Group (DMDG), acting as a course organiser as well as being a part of the Scientific Sub-committee. Graeme is a Fellow of the Royal Society of Chemistry (FRSC) and has authored over 20 peer reviewed articles as well as several Book Chapters on the application of LC-MS in the pharmaceutical environment.
This email address is being protected from spambots. You need JavaScript enabled to view it.
 
XXXiaobin Xu BSc MSc PhD (Regeneron Pharmaceuticals, Tarrytown, NY, USA).
Xiaobin is a Scientist at Regeneron Pharmaceuticals. He received his B.S. and M.S. in Chemistry from Sichuan University, China. He did his Ph. D. in Prof. Catherine E. Costello’s lab at Boston University, where he focused on proteomics and biological applications of mass spectrometry. At Regeneron, he leads and performs analytical characterization of therapeutic proteins to support pre-clinical and clinical development. In addition, he develops new analytical methods and technologies to better characterize monoclonal antibodies (mAbs). His research interests include mass spectrometry based therapeutic protein/biomarker quantification, hydrogen deuterium exchange mass spectrometry (HDX-MS) and chemical cross-linking mass spectrometry for protein conformation and protein-protein interaction studies, post-translational modifications, top-down mass spectrometry, host cell protein identification and quantification, separation of mAbs and mAb fragments, and bioanalytical method development and validation.
This email address is being protected from spambots. You need JavaScript enabled to view it.
 
MC 96x96Mu Chen PhD (Frontage Labs, Exton, PA, USA).
Mu Chen obtained his Ph.D. degree in Dr. Jeehiun K. Lee's research group at Rutgers University, the State University of New Jersey. His Ph.D. research focused on the characterization of novel organic compounds, damaged nucleobases, and RNA oligonucleotides by using analytical methods based on mass spectrometry and LC-MS/MS. In 2014, Mu Chen joined Frontage Labs, a leading CRO company in bioanalysis (Exton, PA). He participated in many research projects in which bioanalytical methods were developed to support pharmaceutical R&D. He is experienced with HPLC separation, mass spectrometry optimization and instrumentation, and pretreatment of biological samples in various matrices, from both theoretical and practical perspectives. His recent interest has also shifted to quantitation of large molecule drugs (oligonucleotides, therapeutic monoclonal antibodies, peptides) by using both immunogenicity and mass spectrometry platforms.
This email address is being protected from spambots. You need JavaScript enabled to view it.
 
VS 96x96Victoria Samanidou PhD (Aristotle University of Thessaloniki, Thessaloniki, Greece).
Dr Victoria Samanidou is a Professor of Analytical Chemistry in the Chemistry Department of the Aristotle University of Thessaloniki (Greece). Her current research activities include: Modern sample preparation techniques used in the development of validated HPLC and GC methods for the determination of inorganic and organic substances in biological samples, pharmaceuticals, forensics and toxicology samples, food, samples of environmental interest. She has published more than 130 original research articles in peer reviewed journals and 50 reviews and chapters in scientific books. H-index 25 (source Scopus May 2016). She is member of editorial board of more than 10 scientific journals and she has reviewed almost 350 manuscripts in more than 80 scientific journals. She was also guest editor in 2 special issues in scientific journals.
This email address is being protected from spambots. You need JavaScript enabled to view it.
 
AT 96x96Andreas Tsakalof PhD (University of Thessaly, Volos, Greece).
Andreas Tsakalof received the degree in Chemical Engineering in 1977 from Lomonosov Moscow State University of Fine Chemical Technology (Russia) and Ph.D. in Chemistry in 1986 from Russian Academy of Science, Nesmeyanov Institute of Organoelement Compounds (INEOS RAS, Moscow, Russia). In 1998-1999 he was trained in Molecular Toxicology at the University of Surrey, School of Biological Sciences (Guildford, UK) in the framework of the European Marie Curie research fellowship. Nowadays he is Associate Professor of Medical Chemistry at the School of Medicine, University of Thessaly, Greece. Professor A. Tsakalof is European Registered Toxicologist (ERT) by EUROTOX and awarded reviewer from the journals of Toxicology Letters (2011) and Food and Chemical Toxicology (2015). His research interests are nowadays focused on the development and application of new sample preparation and analysis methods in clinical chemistry and toxicology, preparation and use of molecularly imprinted polymers in target separation of bioactive compounds from natural sources.
This email address is being protected from spambots. You need JavaScript enabled to view it.
 
JW96x96Junyi Yang PhD (Frontage Labs, Exton, PA, USA).
is a Senior Scientist in Bioanalytical Services, Frontage Laboratories, Inc, PA, USA. Dr Junyi Yang received Master degree in Food Chemistry at the University of Nebraska-Lincoln, USA and Doctor degree in Food Chemistry and Nutrition at the University of Nebraska-Lincoln, USA. Dr Junyi Yang’s professional interests are 1) Bio-analysis and identification of food and drug bioactive compounds and evaluation their impact on metabolic disease in human and animal trials. 2) Develop and validate new bio-analytical method to support new drug and agri-chemicals analysis using GC/LC/MS/MS.
This email address is being protected from spambots. You need JavaScript enabled to view it.
 
CP96x96Constantinos Pistos PhD (West Chester University, West Chester, PA, USA).
Dr. Pistos graduated from the department of pharmacy of the Aristotle University of Thessaloniki (Greece) on 1995, before he pursued his M.Sc. and Ph.D studies, at the Department of Pharmacy of the University of Athens (Greece). On 2001-2002 he continued his research as postdoctoral fellow at the college of pharmacy of the University of Georgia Athens, GA (U.S.A.), before serving as director of a private CRO pharmaceutical company in Greece. Between 2006 and 2012, he possessed the position of Lecturer and by 2012 of Assistant Professor in Toxicology at the School of Medicine of the University of Athens (Greece). By 2015, Dr. Pistos possesses the position of Assistant Professor of Toxicology at the Department of Chemistry at West Chester University of Pennsylvania, U.S.A. He has published fifty-two articles and four book chapters while he presented thirty-five research works in congresses, in the fields of toxicology and pharmaceutical analysis.
This email address is being protected from spambots. You need JavaScript enabled to view it.
 
KW96x96Kai Wang, PhD (Frontage Laboratories, Inc., Exton, PA, USA).
Dr. Kai Wang is Group Leader of Bioanalytical and Biologics Services at Frontage Laboratories, Inc, a leading global CRO, and has lead more than 100 bioanalytical projects related to the development of pharmaceutical products. Dr. Wang’s current research focus is in the area of bioanalytical method development and validation, including quantitation of small molecule drugs and metabolites, as well as big molecule drugs and biomarkers such as oligonucleotides, proteins, peptides, and glycosaminoglycans. Dr. Wang’s research interest also involves developing bioanalytical methods using novel techniques such as dry blood spot (DBS) sampling, microsampling and analyte derivatization. Dr. Wang earned a doctor of philosophy degree in chemistry from Rutgers University - New Brunswick. He received a bachelor of science degree in chemistry from Nanjing University.
This email address is being protected from spambots. You need JavaScript enabled to view it.
 
DP 96x152Dr. Pantazatos, PhD (Division of Infectious Diseases, Weill Cornell Medical College, New York, NY, USA).
received a BS in Biomedical Engineering from Northwestern University Chicago IL., an MS in Human Genetics from the University of Michigan Ann Arbor, and his PhD from the University of California San Diego. During his graduate studies he applied hydrogen deuterium exchange mass spectrometry (HDXMS) to characterize structure and dynamics of proteins and protein-ligand interactions. He holds one patent in the application of HDXMS for improving protein structure prediction and developed computational methods for determining hydrogen exchange rates from a 3D protein structure and calculating single amide exchange rates from HDX datasets. He completed his postdoctoral training at Harvard Medical School and held a faculty position at Brown Medical School and served as Director of the Center or Biomedical Cancer Research proteomics core. He is currently at Weill Cornell Medical College, NY pursuing research investigating structural mechanisms of drug resistance in antimicrobial target proteins.
This email address is being protected from spambots. You need JavaScript enabled to view it.
 
MF 96x96Morse Faria, PhD (PPD Laboratories, Richmond, VA, USA).
obtained his bachelor degree in Pharmaceutical sciences from Goa University, India in and Master of Pharmacy degree from University of Mumbai, India. He completed his Ph.D. in Pharmaceutical Sciences from Virginia Commonwealth University, USA. He is currently working as a Research Scientist at Pharmaceutical Product Development, USA. Prior to obtaining his Ph.D., Dr. Faria worked as Research Associate at Wockhardt Ltd., Mumbai, India and as a Lecturer in Pharmacy, University of Mumbai, India. He is a reviewer for various bioanalytical journals including Bioanalysis, Journal of Chromatography B and Journal of Pharmaceutical and Biomedical Analysis. Dr. Faria’s main area of research focus is quantitative bioanalysis using liquid chromatography and tandem mass spectrometry (LC-MS/MS). He specializes in bioanalysis of protein molecules (biomarkers and biotherapeutics) from biological specimens to support drug discovery and drug development.
This email address is being protected from spambots. You need JavaScript enabled to view it.
 

Cover new july 2016

Abbrv: J. Appl. Bioanal
eISSN: 2405-710X
CAS Abstracts: CODEN JABODF
Directory of Open Access Journals: DOAJ Seal

Go to top

Betasciencepress Publishing © 2014-2017